Comparative effectiveness of a fixed-dose combination of losartan

被引:10
作者
Radchenko, G. D. [1 ]
Sirenko, Y. M. [1 ]
Kushnir, S. M. [1 ]
Torbas, O. O. [1 ]
Dobrokhod, A. S. [1 ]
机构
[1] Strazhesko Inst Cardiol, Secondary Hypertens Dept, Natl Sci Ctr, 5 Narodnogo Opolchenia Str, UA-03680 Kiev, Ukraine
关键词
arterial hypertension; combination therapy; central blood pressure; arterial stiffness;
D O I
10.2147/VHRM.S44568
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: The aim of this study was to compare the antihypertensive efficacy of losartan 100 mg + hydrochlorothiazide (HCTZ) 25 mg versus bisoprolol 10 mg + HCTZ 25 mg and their influence on arterial stiffness and central blood pressure (BP). Methods: Of 60 patients with a mean BP of 173.3 +/- 1.7/98.4 +/- 1.2 mm Hg, 59 were randomized to losartan + HCTZ (n = 32) or bisoprolol + HCTZ (n = 27). Amlodipine was added if target BP was not achieved at 1 month, and doxazosin was added if target BP was not achieved after 3 months. Body mass index, office and 24-hour ambulatory BP, pulse wave velocity (carotid-femoral [PWVE] and radial [PWVM]), noninvasive central systolic BP, augmentation index (AIx), laboratory investigations, and electrocardiography were done at baseline and after 6 months of treatment. Results: Losartan + HCTZ was as effective as bisoprolol + HCTZ, with target office BP achieved in 96.9% and 92.6% of patients and target 24-hour BP in 75% and 66.7% of patients, respectively, after 6 months. Effective treatment of BP led to significant lowering of central systolic BP, but this was decreased to a significantly (P < 0.05) greater extent by losartan + HCTZ (-23.0 +/- 2.3 mm Hg) than by bisoprolol + HCTZ (-15.4 +/- 2.9 mm Hg) despite equal lowering of brachial BP. Factors correlated with central systolic BP and its lowering differed between the treatment groups. Losartan + HCTZ did not alter arterial stiffness patterns significantly, but bisoprolol + HCTZ significantly increased AIx. We noted differences in Delta PWVE, Delta PWVM, and Delta AIx between the groups in favor of losartan + HCTZ. Decreased heart rate was associated with higher central systolic BP and AIx in the bisoprolol + HCTZ group, but was not associated with increased AIx in the losartan + HCTZ group. Conclusion: Although both treatments decreased both office and 24-hour BP, losartan + HCTZ significantly decreased central systolic BP and had a more positive influence on pulse wave velocity, with a less negative effect of decreased heart rate on AIx and central systolic BP.
引用
收藏
页码:535 / 549
页数:15
相关论文
共 85 条
[1]  
Agabiti-Rosei E, 2009, VASC HEALTH RISK MAN, V5, P353
[2]   Effects of antihypertensive treatment on small artery remodelling [J].
Agabiti-Rosei, Enrico ;
Heagerty, Anthony M. ;
Rizzoni, Damiano .
JOURNAL OF HYPERTENSION, 2009, 27 (06) :1107-1114
[3]   Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population [J].
Antikainen, R ;
Jousilahti, P ;
Tuomilehto, J .
JOURNAL OF HYPERTENSION, 1998, 16 (05) :577-583
[4]   ASSESSMENT OF ARTERIAL DISTENSIBILITY BY AUTOMATIC PULSE-WAVE VELOCITY-MEASUREMENT - VALIDATION AND CLINICAL-APPLICATION STUDIES [J].
ASMAR, R ;
BENETOS, A ;
TOPOUCHIAN, J ;
LAURENT, P ;
PANNIER, B ;
BRISAC, AM ;
TARGET, R ;
LEVY, BI .
HYPERTENSION, 1995, 26 (03) :485-490
[5]   Beta-blockers for primary prevention of heart failure in patients with hypertension - Insights from a meta-analysis [J].
Bangalore, Sripal ;
Wild, David ;
Parkar, Sanobar ;
Kukin, Marrick ;
Messerli, Franz H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (13) :1062-1072
[6]   Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period [J].
Benetos, A ;
Adamopoulos, C ;
Bureau, JM ;
Temmar, M ;
Labat, C ;
Bean, K ;
Thomas, F ;
Pannier, B ;
Asmar, R ;
Zureik, M ;
Safar, M ;
Guize, L .
CIRCULATION, 2002, 105 (10) :1202-1207
[7]  
Benetos A, 2000, Am Heart J, V140, pE11
[8]   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
London, GM .
HYPERTENSION, 2001, 38 (04) :938-942
[9]   Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease [J].
Blacher, J ;
Pannier, B ;
Guerin, AP ;
Marchais, SJ ;
Safar, ME ;
London, GM .
HYPERTENSION, 1998, 32 (03) :570-574
[10]   Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients [J].
Blacher, J ;
Asmar, R ;
Djane, S ;
London, GM ;
Safar, ME .
HYPERTENSION, 1999, 33 (05) :1111-1117